1. Home
  2. CLNE vs CSTL Comparison

CLNE vs CSTL Comparison

Compare CLNE & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNE
  • CSTL
  • Stock Information
  • Founded
  • CLNE 2001
  • CSTL 2007
  • Country
  • CLNE United States
  • CSTL United States
  • Employees
  • CLNE N/A
  • CSTL N/A
  • Industry
  • CLNE Natural Gas Distribution
  • CSTL Medical Specialities
  • Sector
  • CLNE Utilities
  • CSTL Health Care
  • Exchange
  • CLNE Nasdaq
  • CSTL Nasdaq
  • Market Cap
  • CLNE 610.0M
  • CSTL 576.3M
  • IPO Year
  • CLNE 2007
  • CSTL 2019
  • Fundamental
  • Price
  • CLNE $1.57
  • CSTL $20.19
  • Analyst Decision
  • CLNE Strong Buy
  • CSTL Strong Buy
  • Analyst Count
  • CLNE 4
  • CSTL 6
  • Target Price
  • CLNE $4.75
  • CSTL $40.00
  • AVG Volume (30 Days)
  • CLNE 2.5M
  • CSTL 407.2K
  • Earning Date
  • CLNE 05-08-2025
  • CSTL 05-01-2025
  • Dividend Yield
  • CLNE N/A
  • CSTL N/A
  • EPS Growth
  • CLNE N/A
  • CSTL N/A
  • EPS
  • CLNE N/A
  • CSTL 0.62
  • Revenue
  • CLNE $415,865,000.00
  • CSTL $332,069,000.00
  • Revenue This Year
  • CLNE N/A
  • CSTL N/A
  • Revenue Next Year
  • CLNE $13.08
  • CSTL $6.01
  • P/E Ratio
  • CLNE N/A
  • CSTL $32.56
  • Revenue Growth
  • CLNE N/A
  • CSTL 51.09
  • 52 Week Low
  • CLNE $1.50
  • CSTL $16.97
  • 52 Week High
  • CLNE $3.67
  • CSTL $35.84
  • Technical
  • Relative Strength Index (RSI)
  • CLNE 32.59
  • CSTL 40.61
  • Support Level
  • CLNE $1.50
  • CSTL $19.22
  • Resistance Level
  • CLNE $1.79
  • CSTL $20.30
  • Average True Range (ATR)
  • CLNE 0.11
  • CSTL 0.80
  • MACD
  • CLNE 0.02
  • CSTL 0.24
  • Stochastic Oscillator
  • CLNE 17.95
  • CSTL 57.96

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas, and renewable natural gas as an alternative fuel for vehicles. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME, among others. The company's test portfolio consists of test offerings to aid clinicians in the diagnosis and treatment of cancers or precancerous diagnoses in the fields of dermatology, gastroenterology, and ophthalmology and a pharmacogenomics ("PGx") test to guide optimal drug treatment for patients diagnosed with depression, anxiety, and other mental health conditions.

Share on Social Networks: